CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Menopause - Drugs in this topic
Scenario: Postmenopausal with uterus (HRT)
This level contains the following sections:
- Angeliq tablets
- Climesse tablets
- Elleste Duet Conti tablets
- Estring 2mg vaginal ring
- Evorel Conti patches
- Femoston-conti 1mg/5mg tablets
- FemSeven Conti patches
- Indivina 1mg/2.5mg tablets
- Indivina 1mg/5mg tablets
- Indivina 2mg/5mg tablets
- Kliofem tablets
- Kliovance tablets
- Nuvelle Continuous tablets
- Ortho-Gynest 500microgram pessaries
- Ovestin 0.1% cream
- Premique Low Dose modified-release tablets
- Premique tablets
- Tibolone 2.5mg tablets
- Vagifem 25microgram vaginal tablets
© NHS Institute for Innovation and Improvement